All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Addition of ETA receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10293391" target="_blank" >RIV/00216208:11110/14:10293391 - isvavai.cz</a>

  • Alternative codes found

    RIV/67985823:_____/14:00439090 RIV/00216208:11120/14:43909401 RIV/00023001:_____/14:00058789 RIV/00064165:_____/14:10293391

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.lfs.2013.12.018" target="_blank" >http://dx.doi.org/10.1016/j.lfs.2013.12.018</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.lfs.2013.12.018" target="_blank" >10.1016/j.lfs.2013.12.018</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Addition of ETA receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats

  • Original language description

    Aims: There is evidence that in addition to hypertension and hyperactivity of the renin-angiotensin system (RAS), enhanced intrarenal activity of endothelin (ET) system contributes to the pathophysiology and progression of chronic kidney disease (CKD). This prompted us to examine if this progression would be alleviated by addition of type A ET receptor (ETA) blockade to the standard blockade of RAS. Main methods: Ren-2 transgenic rats (TGR) after 5/6 renal ablation (5/6 NX) served as a model of CKD. ForRAS inhibition a combination of angiotensin-converting enzyme inhibitor (trandolapril, 6 mg/L drinking water) and angiotensin II type 1 receptor blocker (Iosartan, 100 mg/L drinking water) was used. Alternatively, ETA receptor blocker (atrasentan, 5 mg.kg(-1).day(-1) in drinking water) was added to the combined RAS blockade. The follow-up period was 44 weeks after 5/6 NX. and the rats' survival rate, systolic blood pressure (SOP), proteinuria and indices of renal glomerular damage were

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FE - Other fields of internal medicine

  • OECD FORD branch

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    O - Projekt operacniho programu

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Life Sciences

  • ISSN

    0024-3205

  • e-ISSN

  • Volume of the periodical

    118

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

    297-305

  • UT code for WoS article

    000348167700036

  • EID of the result in the Scopus database